Yadav et al. reported CBC risk estimates among breast cancer survivors carrying P/LP variants in the ATM, BRCA1, BRCA2, CHEK2, and PALB2 genes from the CARRIERS study [47]. This evidence concerns the gene ATM and breast carcinoma.